The clinical prognostic differences were consistent from DSS and PFI analysis (Figure 4D-I), which indicated that the m6A risk model composed of four genes (KIAA1429, LRPPRC, RBM15B, and YTHDF2) can more accurately predict the prognosis of A-HCC. The gene discussed is YTHDF2; the disease is hepatocellular carcinoma.